PubRank

Peter B Barker

Author PubWeight™ 118.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Multi-parametric neuroimaging reproducibility: a 3-T resource study. Neuroimage 2010 3.32
2 Re-examining the brain regions crucial for orchestrating speech articulation. Brain 2004 3.23
3 Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleep. Neurology 2013 2.79
4 Change in perfusion in acute nondominant hemisphere stroke may be better estimated by tests of hemispatial neglect than by the National Institutes of Health Stroke Scale. Stroke 2003 2.61
5 Diffusion tensor imaging in children and adolescents: reproducibility, hemispheric, and age-related differences. Neuroimage 2006 2.21
6 Spatial effects in the detection of gamma-aminobutyric acid: improved sensitivity at high fields using inner volume saturation. Magn Reson Med 2007 1.91
7 Childhood obstructive sleep apnea associates with neuropsychological deficits and neuronal brain injury. PLoS Med 2006 1.91
8 Anatomy of spatial attention: insights from perfusion imaging and hemispatial neglect in acute stroke. J Neurosci 2005 1.75
9 Restoring cerebral blood flow reveals neural regions critical for naming. J Neurosci 2006 1.60
10 Human brain hemorrhage: quantification of perihematoma edema by use of diffusion-weighted MR imaging. AJNR Am J Neuroradiol 2002 1.59
11 Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid–edited MR spectroscopy spectra. J Magn Reson Imaging 2013 1.57
12 In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla. Magn Reson Med 2007 1.55
13 Clinical proton MR spectroscopy in central nervous system disorders. Radiology 2014 1.53
14 Subcortical brain atrophy persists even in HAART-regulated HIV disease. Brain Imaging Behav 2011 1.53
15 Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain. Magn Reson Med 2010 1.52
16 Quantitative MR spectroscopic imaging of brain lesions in patients with AIDS: correlation with [11C-methyl]thymidine PET and thallium-201 SPECT. Acad Radiol 2002 1.43
17 Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement. J Magn Reson Imaging 2013 1.43
18 Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 2004 1.40
19 Macromolecule-suppressed GABA-edited magnetic resonance spectroscopy at 3T. Magn Reson Med 2012 1.33
20 Imaging of brain tumors: MR spectroscopy and metabolic imaging. Neuroimaging Clin N Am 2010 1.31
21 Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study. Toxicol Sci 2006 1.30
22 In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. Schizophr Bull 2012 1.28
23 In vivo quantitative proton MRSI study of brain development from childhood to adolescence. J Magn Reson Imaging 2002 1.27
24 Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology 2011 1.27
25 Measuring T2 in vivo with J-difference editing: application to GABA at 3 Tesla. J Magn Reson Imaging 2011 1.24
26 Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology 2002 1.21
27 A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia. J Magn Reson Imaging 2005 1.17
28 Regional apparent metabolite concentrations in young adult brain measured by (1)H MR spectroscopy at 3 Tesla. J Magn Reson Imaging 2008 1.16
29 Variability in subcortical aphasia is due to variable sites of cortical hypoperfusion. Brain Lang 2004 1.15
30 Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study. Magn Reson Imaging 2010 1.14
31 High resolution spectroscopic imaging of GABA at 3 Tesla. Magn Reson Med 2010 1.13
32 Acceleration of 1H MR metabolic imaging with compressed sensing. Radiology 2013 1.10
33 Impact of frequency drift on gamma-aminobutyric acid-edited MR spectroscopy. Magn Reson Med 2013 1.10
34 Dynamic MR perfusion and proton MR spectroscopic imaging in Sturge-Weber syndrome: correlation with neurological symptoms. J Magn Reson Imaging 2006 1.09
35 Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging 2005 1.08
36 Benign and malignant breast lesions: diagnosis with multiparametric MR imaging. Radiology 2003 1.07
37 MR spectroscopy and spectroscopic imaging of the brain. Methods Mol Biol 2011 1.07
38 Edited magnetic resonance spectroscopy detects an age-related decline in brain GABA levels. Neuroimage 2013 1.06
39 Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR Am J Neuroradiol 2003 1.05
40 Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast. J Magn Reson Imaging 2009 1.05
41 Quantification of muscle choline concentrations by proton MR spectroscopy at 3 T: technical feasibility. AJR Am J Roentgenol 2010 1.05
42 Asymmetry and gender effect in functionally lateralized cortical regions: a proton MRS imaging study. J Magn Reson Imaging 2004 1.04
43 Diffusion- and perfusion-weighted magnetic resonance imaging of the brain before and after coronary artery bypass grafting surgery. Stroke 2002 1.04
44 Optimized detection of lactate at high fields using inner volume saturation. Magn Reson Med 2006 1.02
45 White matter alterations in deficit schizophrenia. Neuropsychopharmacology 2008 1.02
46 Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging 2006 1.01
47 Correction of symptomatic cerebral malperfusion due to acute type I aortic dissection by transcarotid stenting of the innominate and carotid arteries. J Vasc Surg 2006 1.00
48 Assessment of transient ischemic attack with diffusion- and perfusion-weighted imaging. AJNR Am J Neuroradiol 2004 0.99
49 A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med 2008 0.99
50 A feasibility study of quantitative molecular characterization of musculoskeletal lesions by proton MR spectroscopy at 3 T. AJR Am J Roentgenol 2010 0.98
51 Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer. Acad Radiol 2010 0.98
52 Dual-band water and lipid suppression for MR spectroscopic imaging at 3 Tesla. Magn Reson Med 2010 0.98
53 Scan time reduction in proton magnetic resonance spectroscopic imaging of the human brain. Magn Reson Med 2002 0.98
54 Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. AJR Am J Roentgenol 2007 0.97
55 Brain metabolite alterations and cognitive dysfunction in early Huntington's disease. Mov Disord 2012 0.97
56 Neural correlates of modality-specific spatial extinction. J Cogn Neurosci 2006 0.96
57 Measuring the longitudinal relaxation time of GABA in vivo at 3 Tesla. J Magn Reson Imaging 2012 0.94
58 Quantitative SENSE-MRSI of the human brain. Magn Reson Imaging 2010 0.94
59 Investigating axonal damage in multiple sclerosis by diffusion tensor spectroscopy. J Neurosci 2012 0.94
60 Reproducibility of brain spectroscopy at 7T using conventional localization and spectral editing techniques. J Magn Reson Imaging 2013 0.93
61 Measurement of T1 and T2 in the cervical spinal cord at 3 tesla. Magn Reson Med 2008 0.93
62 J-difference editing of gamma-aminobutyric acid (GABA): simulated and experimental multiplet patterns. Magn Reson Med 2012 0.93
63 Multiparametric and multinuclear magnetic resonance imaging of human breast cancer: current applications. Technol Cancer Res Treat 2004 0.92
64 An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy. JAMA Neurol 2013 0.92
65 Brain metabolism in Rett syndrome: age, clinical, and genotype correlations. Ann Neurol 2009 0.92
66 Simultaneous water and lipid suppression for in vivo brain spectroscopy in humans. Magn Reson Med 2005 0.91
67 Perfusion-weighted magnetic resonance imaging in adult moyamoya syndrome: characteristic patterns and change after surgical intervention: case report. Neurosurgery 2002 0.91
68 Noninvasive assessment of brain injury in a canine model of hypothermic circulatory arrest using magnetic resonance spectroscopy. Ann Thorac Surg 2006 0.90
69 If J doesn't evolve, it won't J-resolve: J-PRESS with bandwidth-limited refocusing pulses. Magn Reson Med 2011 0.90
70 Arrival time correction for dynamic susceptibility contrast MR permeability imaging in stroke patients. PLoS One 2012 0.90
71 Diffusion tensor-based imaging reveals occult abnormalities in adrenomyeloneuropathy. Ann Neurol 2005 0.90
72 Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 2002 0.89
73 Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia. Radiology 2010 0.89
74 Molecular characterization of musculoskeletal tumors by proton MR spectroscopy. Semin Musculoskelet Radiol 2007 0.88
75 Early characteristics of Sturge-Weber syndrome shown by perfusion MR imaging and proton MR spectroscopic imaging. AJNR Am J Neuroradiol 2003 0.88
76 Quantitative proton magnetic resonance spectroscopic imaging: regional variations in the corpus callosum and cortical gray matter. J Magn Reson Imaging 2005 0.88
77 Longitudinal and multi-echo transverse relaxation times of normal breast tissue at 3 Tesla. J Magn Reson Imaging 2010 0.88
78 Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children. J Magn Reson Imaging 2006 0.87
79 Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis. Proc Natl Acad Sci U S A 2012 0.85
80 Regions of neural dysfunction associated with impaired naming of actions and objects in acute stroke. Cogn Neuropsychol 2002 0.85
81 Spin-echo magnetic resonance spectroscopic imaging at 7 T with frequency-modulated refocusing pulses. Magn Reson Med 2012 0.85
82 Susceptibility-based analysis of dynamic gadolinium bolus perfusion MRI. Magn Reson Med 2014 0.84
83 GABA predicts inhibition of frequency-specific oscillations in schizophrenia. J Neuropsychiatry Clin Neurosci 2013 0.84
84 Proton magnetic resonance spectroscopic imaging in pediatric pilomyxoid astrocytoma. Childs Nerv Syst 2004 0.84
85 Quantitative proton MR spectroscopic imaging of the mesial temporal lobe. J Magn Reson Imaging 2004 0.83
86 A neurologic presentation of familial hemophagocytic lymphohistiocytosis which mimicked septic emboli to the brain. J Child Neurol 2007 0.83
87 Quantitative cerebral blood flow in dynamic susceptibility contrast MRI using total cerebral flow from phase contrast magnetic resonance angiography. Magn Reson Med 2011 0.83
88 Neural regions essential for writing verbs. Nat Neurosci 2003 0.82
89 MRI-guided vacuum-assisted breast biopsy: a phantom and patient evaluation of targeting accuracy. J Magn Reson Imaging 2009 0.82
90 1H Magnetic resonance spectroscopy findings in idiopathic inflammatory myopathies at 3 T: feasibility and first results. Invest Radiol 2013 0.82
91 Decreased γ-aminobutyric acid levels in the parietal region of patients with Alzheimer's disease. J Magn Reson Imaging 2014 0.81
92 Readdressing synaptic pruning theory for schizophrenia: Combination of brain imaging and cell biology. Commun Integr Biol 2011 0.81
93 Exploring the relationship of macrophage colony-stimulating factor levels on neuroaxonal metabolism and cognition during chronic human immunodeficiency virus infection. J Neurovirol 2010 0.80
94 Effects of Ginkgo biloba on cerebral blood flow assessed by quantitative MR perfusion imaging: a pilot study. Neuroradiology 2011 0.80
95 Characteristic MR imaging changes in severe hypermethioninemic states. AJNR Am J Neuroradiol 2005 0.80
96 Etiology of perfusion-diffusion magnetic resonance imaging mismatch patterns. J Neuroimaging 2005 0.79
97 Metabolites in ventricular cerebrospinal fluid detected by proton magnetic resonance spectroscopic imaging. J Magn Reson Imaging 2004 0.79
98 Proton MR spectroscopic imaging in Pelizaeus-Merzbacher disease. AJNR Am J Neuroradiol 2003 0.79
99 Neuroimaging of phakomatoses. Semin Pediatr Neurol 2006 0.78
100 Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: a pilot investigation comparing treatment responders and non-responders. Psychiatry Res 2007 0.78
101 Magnetic resonance spectroscopy: a new guide for the therapy of adrenoleukodystrophy. Neurology 2005 0.78
102 Neuroanatomical correlates of depression in post traumatic brain injury: preliminary results of a pilot study. J Neuropsychiatry Clin Neurosci 2010 0.78
103 Proton MR spectroscopic imaging of the medulla and cervical spinal cord. J Magn Reson Imaging 2007 0.78
104 Diffusion-perfusion MR evaluation and spectroscopy before and after surgical therapy for intracerebral hemorrhage. Neurocrit Care 2005 0.77
105 Gray matter in amnestic mild cognitive impairment: voxel-based morphometry. Neuroreport 2010 0.77
106 Fast method for brain image segmentation: application to proton magnetic resonance spectroscopic imaging. Magn Reson Med 2005 0.77
107 Determining the in vivo transverse relaxation time of GABA in the human brain at 7T. J Magn Reson Imaging 2012 0.76
108 Novel proton MR spectroscopy findings in adenylosuccinate lyase deficiency. J Magn Reson Imaging 2012 0.75
109 3T MR with diffusion tensor imaging and single-voxel spectroscopy in giant axonal neuropathy. J Magn Reson Imaging 2008 0.75
110 Transcranial Doppler markers of diffusion-perfusion mismatch. J Neuroimaging 2003 0.75
111 Proton MR spectroscopy in hyperhomocysteinemia with elevated blood methionine levels. J Magn Reson Imaging 2006 0.75